BARDA, Emergent BioSolutions break off $600M Covid-19 vaccine manufacturing deal
After a fiasco surrounding the contamination of Covid-19 vaccine doses in its facilities — during a time in which vaccinating residents was dire to America’s return …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.